瘢痕疙瘩病灶内注射曲安奈德与5-氟尿嘧啶的随机对照试验
两组6个月缓解率无统计学差异(5-FU组46% vs TAC组60%)。TAC组局部不良反应更高:皮肤萎缩44% vs 8%(p<0.05),毛细血管扩张50% vs 21%(p<0.05)。组织学上TAC组血管密度和Ki-67增殖指数均下降,而5-FU组血管密度无变化、增殖指数升高。
要点
- TAC与5-FU注射治疗瘢痕疙瘩6个月缓解率无显著差异(46% vs 60%)。
- TAC组皮肤萎缩和毛细血管扩张发生率显著高于5-FU组(p<0.05)。
- 美容敏感部位可优先考虑5-FU注射以减少局部不良反应。
核心结论
- TAC与5-FU病灶内注射治疗瘢痕疙瘩的临床疗效无统计学差异。
- 5-FU注射局部不良反应更少,可能更适合美容敏感区域。
主要发现
- 6个月缓解率:5-FU组46%,TAC组60%,两组无统计学显著差异。
- 皮肤萎缩发生率:TAC组44%,5-FU组8%(p<0.05)。
- 毛细血管扩张发生率:TAC组50%,5-FU组21%(p<0.05)。
- TAC组治疗后瘢痕血管密度下降(p<0.05),5-FU组无变化。
- Ki-67评估的成纤维细胞增殖:TAC组显著下降(p<0.05),5-FU组显著升高(p<0.05)。
临床怎么用
- 临床选择注射药物时需权衡疗效与局部不良反应,美容敏感部位可优先考虑5-FU。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Keloids have high recurrence rates. Current first-line therapy is triamcinolone (TAC) injection, but it has been suggested that approximately 50% of keloids are steroid resistant. We compared the efficacy of intralesional 5-fluorouracil (5-FU) and triamcinalone injections in a double-blind randomized controlled trial. Forty-three patients with 50 keloid scars were treated with either intralesional TAC or 5-FU-injections over 6 months. There was no statistically significant difference in the remission rate at 6 months between the 5-FU and TAC groups (46% vs 60%, respectively). Local adverse effects were higher in the TAC group compared to the 5-FU group. Occurrence of skin atrophy in TAC group was 44% and in the 5-FU group 8% (p < 0.05). Also the occurrence of telangiectasia in the TAC group was 50% and in the 5-FU 21% (p < 0.05). Vascularity of the keloids, assessed by spectral imaging and immunohistochemical staining for blood vessels, after treatment decreased in the TAC group, but not in the 5-FU group (p < 0.05). Fibroblast proliferation evaluated by Ki-67 staining significantly decreased in the TAC group (p < 0.05) but increased in the 5-FU group (p < 0.05). TAC and 5-FU injections did not differ in their clinical effectivity in this randomized study, but 5-FU injections lead to increased proliferation rate and did not affect vascular density in histological assessment. Due to the greater number of adverse effects observed after TAC treatment, 5-FU injections may be preferable for cosmetically sensitive skin areas.
引用
- Hietanen KE, Järvinen TA, Huhtala H, et al. Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections - a randomized controlled trial. J Plast Reconstr Aesthet Surg. 2018. PMID: 30448246. doi:10.1016/j.bjps.2018.05.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。